Invivyd, Inc. (IVVD) vs ProQR Therapeutics N.V. (PRQR)

Invivyd, Inc. and ProQR Therapeutics N.V. are both Biotechnology companies. Invivyd, Inc. and ProQR Therapeutics N.V. are of similar size ($196.1M and $190.4M). Invivyd, Inc. grew revenue faster over the last twelve months: 26.3% against 19.7%. Invivyd, Inc. has the higher net margin (−183.9% vs −228.7%) and the lower return on invested capital (−334.9% vs 0.00%). Across the 17 metrics below, Invivyd, Inc. leads on 10 and ProQR Therapeutics N.V. on 7.

Valuation

Metric IVVD PRQR Biotechnology median
P/E n/m n/m 8.42
P/S 3.68 7.43 10.01
P/B 1.19 1.73 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 0.94 1.57 9.41
Earnings yield (49.25%) (31.72%) (31.85%)
Free cash flow yield (51.08%) (35.99%) (24.58%)

Profitability

Metric IVVD PRQR Biotechnology median
Gross margin 92.23% 100.00% 65.16%
Operating margin (192.81%) (233.33%) 0.00%
Net margin (183.90%) (228.71%) 0.00%
Free cash flow margin (187.88%) (267.36%) 0.00%
Return on equity (95.89%) (58.29%) (56.36%)
Return on assets (69.69%) (31.53%) (48.04%)
Return on invested capital (334.92%) 0.00% 0.00%

Growth

Metric IVVD PRQR Biotechnology median
Revenue growth (TTM) 26.30% 19.72% 6.02%
EPS growth (last fiscal year) 79.02% (28.57%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IVVD PRQR Biotechnology median
Debt to equity 0.00 0.06 0.00
Current ratio 5.87 3.49 4.72
Net debt to EBITDA 4.24 2.15 0.96

Dividend

Metric IVVD PRQR Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric IVVD PRQR Biotechnology median
Market cap 190.41m 196.09m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack